Literature DB >> 9092705

Purification and characterisation of a plasminogen-binding protein from Haemophilus influenzae. Sequence determination reveals identity with aspartase.

I Sjöström1, H Gröndahl, G Falk, G Kronvall, M Ullberg.   

Abstract

Plasminogen binding proteins have been described both for Gram positive and Gram negative bacteria. In the present work we describe the purification and characterization of a plasminogen binding protein from Haemophilus influenzae (strain HI-23459). Bacteria were sonicated in order to solubilize plasminogen-binding proteins. The supernatant was subjected to affinity chromatography on plasminogen kringle-4 fragment bound to Sepharose 4B and subsequently processed by ion-exchange chromatography on DEAE-Sepharose CL-6B. Characterization of the protein by SDS-PAGE displayed a single band with a molecular mass of about 55,000, both prior to and after reduction. The purified protein stimulates tPA (tissue plasminogen activator) catalysed plasminogen activation by a factor of approximately 300, mainly due to a decrease in K(m). Antibodies were raised in rabbits and used in quantitative and qualitative analysis. However, using a FITC-conjugate we failed to demonstrate the presence of the purified protein on the surface of intact bacteria. The corresponding gene was isolated from a lambda EMBL3 phage library prepared from chromosomal DNA from the same H. influenzae strain, using an oligonucleotide probe based on the NH2-terminal amino acid sequence. An open reading frame corresponding to 472 amino acid was found. The amino acid sequence of the translated gene demonstrates 97% identity with the recently published sequence from aspartate ammonia lyase (aspartase) from H. influenzae. Enzymatic analysis of the purified protein revealed a high aspartase activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092705     DOI: 10.1016/s0005-2736(96)00218-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Enzymes involved in anaerobic respiration appear to play a role in Actinobacillus pleuropneumoniae virulence.

Authors:  Ilse Jacobsen; Isabel Hennig-Pauka; Nina Baltes; Matthias Trost; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.

Authors:  M Pantzar; A Ljungh; T Wadström
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  Moraxella catarrhalis Binds Plasminogen To Evade Host Innate Immunity.

Authors:  Birendra Singh; Tamim Al-Jubair; Chandrashekar Voraganti; Tobias Andersson; Oindrilla Mukherjee; Yu-Ching Su; Peter Zipfel; Kristian Riesbeck
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

4.  Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins.

Authors:  Klas Jönsson; Betty P Guo; Hans-Jürg Monstein; John J Mekalanos; Göran Kronvall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

5.  Physical Features of Intracellular Proteins that Moonlight on the Cell Surface.

Authors:  Vaishak Amblee; Constance J Jeffery
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

6.  Lipoprotein(a), an Opsonin, Enhances the Phagocytosis of Nontypeable Haemophilus influenzae by Macrophages.

Authors:  Zhi Liu; Yuxin Li; Yu Wang; Zhe Liu; Yan Su; Qiang Ma; Runlin Han
Journal:  J Immunol Res       Date:  2021-11-02       Impact factor: 4.818

Review 7.  Bacterial plasminogen receptors: mediators of a multifaceted relationship.

Authors:  Martina L Sanderson-Smith; David M P De Oliveira; Marie Ranson; Jason D McArthur
Journal:  J Biomed Biotechnol       Date:  2012-10-14

8.  Fructose-1,6-bisphosphate aldolase of Neisseria meningitidis binds human plasminogen via its C-terminal lysine residue.

Authors:  Fariza Shams; Neil J Oldfield; Si Kei Lai; Sarfraz A Tunio; Karl G Wooldridge; David P J Turner
Journal:  Microbiologyopen       Date:  2016-01-05       Impact factor: 3.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.